Rabies virus inactivation by binary ethylenimine: new method for inactivated vaccine production
- 1 February 1980
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 11 (2) , 120-122
- https://doi.org/10.1128/jcm.11.2.120-122.1980
Abstract
The inactivation dynamics of rabies virus (PV strain) by binary ethylenimine, and the immunogenic properites and the stability of the vaccines prepared using this agent, were studied. Binary ethylenimine at a final concentration of 0.01 M was prepared wtih 2-bromoethylamine hydrobromide in alkaline solutions, either separately from or in suspensions of rabies virus propagated in BHK cells. The infectivity of virus suspensions containing more than 108 plaque-forming units per 0.1 ml was inactivated in 2 h when the inactivating agent was prepared before its addition to the suspensions, and in3 h when prepared directly in the suspensions. Liquid vaccines prepared in this manner and stored at different temperatures maintained potency for 1 month at 37 degrees C and for 6 months at 4 degrees C and 22 to 25 degrees C. Lyophilized vaccine maintained its potency for 6 months at the three temperatures. The inactivated vaccine mixed with aluminum or oil adjuvant at high dilutions protected guinea pigs against challenge. This safer procedure for rabies virus inactivation offers promise for the production of effective vaccines for the immunization of dogs and cattle.This publication has 17 references indexed in Scilit:
- Ethylenimine-inactivated rabies vaccine of tissue culture originJournal of Clinical Microbiology, 1976
- Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine productionArchiv für die gesamte Virusforschung, 1975
- Antigenic Properties of Rabies Virus ComponentsThe Journal of Immunology, 1973
- [Characteristics of a rabies virus strain isolated from the brain of Desmodus rotundus].1972
- Immunogenicity of rabies virus inactivated by -propiolactone, acetylethyleneimine, and ionizing irradiation.1972
- Rabies vaccines: duration-of-immunity study in dogs.1971
- [Realization of a new rabies vaccinefrom cellular culture].1967
- Reproducible plaquing system for rabies, lymphocytic choriomeningitis,k and other ribonucleic acid viruses in BHK-21-13S agarose suspensions.1967
- Purified Rabies Vaccine: Development and Comparison of Potency and Safety with Two Human Rabies VaccinesThe Journal of Immunology, 1967
- A new antirabies vaccine for human use; clinical and laboratory results using rabies vaccine made from embryonated duck eggs.1955